T Cell Subpopulations and IL-2R in Vitiligo

Journal of Dermatology

Volumn 31, Issue 2, 2004, Pages 94-97

  Gunduz, Kamer ^a,c   Ozturk, Gunseli ^b   Terzioglu, Ender ^b   Sebik, Filiz ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

IL 2R; Immunity; T lymphocytes; Vitiligo

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HUMAN; MALE; NATURAL KILLER CELL; T LYMPHOCYTE SUBPOPULATION; VITILIGO;

EID: 1542366534     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00514.x     Document Type: Article

References (22)

1. Kemp EH, Waterman EA, Hawes BE, et al: The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo, J Clin Invest, 109: 923-930, 2002.
2. Kemp EH, Waterman EA, Weetman AP: Antoimmune aspects of vitiligo, Autoimmunity, 34: 65-77, 2001.
3. Mahmoud F, Abul H, al-Saleh O, Haines D, Burleson J, Morgan G: Peripheral T-cell activation in non-segmental vitiligo, J Dermatol, 25: 637-640, 1998.
4. al-Fouzan A, al-Arbash M, Fouad F, Kaaba SA, Mousa MA, al-Harbi SA: Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients, Eur J Immunogenet, 22: 209-213, 1995.
5. Hann SK, Park YK, Chung KY, Kim HI, Im S, Won JH: Peripheral blood lymphocyte imbalance in Koreans with active vitiligo, Int J Dermatol, 32: 286-289, 1993.
6. Abdel-Naser MB, Ludwig WD, Gollnick H, Orfanos CE: Nonsegmental vitiligo: Decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation, Int J Dermatol, 31: 321-326, 1992.
7. Mozzanica N, Frigerio U, Finzi AF, et al: T cell subpopulations in vitiligo: A chronobiologic study, J Am Acad Dermatol, 22: 223-230, 1990.
8. Halder RM, Walters CS, Johnson BA, Chakrabarti SG, Kenney JA Jr: Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study, J Am Acad Dermatol, 14: 733-737, 1986.
9. Yeo UC, Yang YS, Park KB, et al: Serum concentrations of the soluble interleukin-2 receptor in vitiligo patients, J Dermatol Sci, 19: 182-188, 1999.
10. Caixia T, Hongwen F, Xiran L: Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo, J Dermatol Sci, 21: 59-62, 1999.
11. Ortonne JP, Alario A: T and B lymphocytes in vitiligo, Arch Dermatol Res, 261: 147-151, 1978.
12. Soubiran P, Benzaken S, Bellet C, Lacour JP, Ortonne JP: Vitiligo: Peripheral T-cell subset imbalance as defined by monoclonal antibodies, Br J Dermatol, 113 (suppl 28): 124-127, 1985.
13. Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly AP, Alfred L: T cell profiles in vitiligo, J Am Acad Dermatol, 14: 196-201, 1986.
14. Vignale R, Paciel J, Calandria L: Immunological changes in common vitiligo, Med Cutan Ibero Lat Am, 16: 343-347, 1988.
15. Mahmoud F, Abul H, Haines D, Al-Saleh C, Khajeji M, Whaley K: Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+ CD45RO+ and CD4+ CD25+ of T-helper cells in non-segmental vitiligo, J Dermatol 29: 68-73, 2002.
16. Yamauchi PS, Nguyen NQ, Grimes PE: Idiopathic CD4+ T-cell lymphocytopenia associated with vitiligo, J Am Acad Dermatol, 46: 779-782, 2002.
17. Le Poole IC, Van den Wijngaard RM, Westerhof W, Das PK: Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance, Am J Pathol, 148: 1219-1228, 1996.
18. Badri AM, Todd PM, Garioch JJ, Stewart DG, Goudie RB: An immunohistological study of cutaneous lymphocytes in vitiligo, J Pathol, 170: 149-155, 1993.
19. Van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P: Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site, Lab Invest, 80: 1299-1309, 2000.
20. Lang KS, Caroli CC, Muhm A, et al: HLA-A2 restricted, melanocyte-specific CD8 (+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against Melan A/MART1, J Invest Dermatol, 116: 891-897, 2001.
21. Honda Y, Okubo Y, Koga M: Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo, J Dermatol, 24: 561-563, 1997.
22. Gross A, Tapia FJ, Mosca W, et al: Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo, Histol Histopathol, 2: 277-283, 1987.